610-P: Effect of Butyrate on GI signs, SIBO, and Diabetes Control-Randomized, Placebo-Controlled Study in Patients with Type 2 Diabetes

Introduction & Objective: Patients with type 2 DM have frequently GI signs/symptoms and small intestinal bacterial overgrowth (SIBO), which may impair beta cell function and diabetes control. The study aimed to evaluate the influence of microencapsulated oral sodium butyrate on GI signs, SIBO in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1
Hauptverfasser:	Panufnik, Paulina, Wiecek, Martyna, Szwarc, Paulina, Kaniewska, Magdalena, Lewandowski, Konrad, Franek, Edward, Rydzewska, Grazyna
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Beta cells Body mass index Constipation Diabetes Diabetes mellitus (non-insulin dependent) Diarrhea Dietary supplements Pain Placebos Small intestine Sodium butyrate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!